Kimberly-Clark Announces Third Quarter 2010 Results
3Q Net Sales Increased 1 Percent to $5.0 Billion
EPS of $1.14 Compared With Record EPS of $1.40 in 3Q '09
Cost Savings $95 Million; Continued Increases in Strategic Marketing and
Innovation Investments
Headwind from Cost Inflation $265 Million
Company Updates Guidance for 2010 Adjusted EPS to Incorporate Organic
Sales
Growth at Low End of Target Range and Cost Inflation Toward High End of
Previous Expectation
</pre>
<p><span class="xn-location">DALLAS</span>, <span class="xn-chron">Oct. 26</span> /CNW/ -- Kimberly-Clark Corporation (NYSE: KMB) today reported that net sales in the third quarter of 2010 increased 1.3 percent to <span class="xn-money">$5.0 billion</span>. Organic sales rose 1 percent, driven by higher sales volumes of 1 percent, while net selling prices were even with year-ago levels. The I-Flow Corporation acquisition completed in 2009 added an additional point of sales growth, while changes in foreign currency rates reduced sales by 1 percent. The growth in organic sales volumes was highlighted by a 5 percent gain for the company's personal care business, with broad-based strength in most regions of the world. However, volumes declined in the company's K-C Professional business in a challenging economic environment, and in Kimberly-Clark's operations in <span class="xn-location">Venezuela</span>.</p>
<p/>
<p>Diluted net income per share for the quarter was <span class="xn-money">$1.14</span> compared with all-time record results of <span class="xn-money">$1.40</span> in 2009. Although performance benefited from organic top-line volume growth and significant cost savings, bottom-line results declined, primarily due to cost inflation of <span class="xn-money">$265 million</span>. Meanwhile, the company continued to invest to support its brands and future growth opportunities, as both strategic marketing and research and development spending increased faster than sales in the quarter.</p>
<p/>
<p>Chairman and Chief Executive Officer Thomas J. Falk said, "We continue to execute our Global Business Plan strategies in a difficult environment. We leveraged innovation and targeted growth initiatives to deliver excellent volume performance in Personal Care, in most of K-C International and in higher-margin portions of Health Care and K-C Professional. Our financial and cost discipline led to another quarter of significant cost savings and shareholder-friendly deployment of cash flow. Finally, we continued to invest for the future, as we increased investment in strategic marketing and innovation again in the third quarter. On the other hand, the challenging business environment weighed on our bottom-line results more than we previously expected, with relatively soft market demand, cost inflation and slightly higher competitive spending. That said, I'm encouraged with our market positions and believe that we are doing the right things for the long-term success of our brands and our company."</p>
<pre>
Review of third quarter sales by business segment
</pre>
<p>Sales of personal care products increased 2.4 percent compared with the third quarter of 2009. Sales volumes rose 5 percent, while changes in net selling prices, product mix and currency rates each reduced sales by approximately 1 percent.</p>
<p/>
<p>Personal care sales in <span class="xn-location">North America</span> increased 4 percent versus the third quarter of 2009. Sales volumes were up more than 5 percent and changes in currency rates provided a slight benefit to sales. On the other hand, net selling prices fell about 1 percent, driven by a planned increase in promotional activity, and changes in product mix reduced sales by approximately 1 percent. Feminine care sales volumes grew at a double-digit rate for the third consecutive quarter as a result of the U by Kotex line extension. Adult care volumes also increased double-digits, with benefits from recent innovation on the Poise and Depend brands and supporting marketing campaigns. Child care volumes increased 6 percent in conjunction with market share gains. Huggies diaper volumes were up 1 percent and baby wipe volumes were even with the prior-year.</p>
<p/>
<p>In <span class="xn-location">Europe</span>, personal care sales fell 5 percent in the quarter, including a negative currency effect of 9 percent. Sales volumes were up 6 percent, with mid-single digit growth in Huggies diapers and strong performance in baby wipes and child care, while changes in net selling prices reduced sales by 2 percent.</p>
<p/>
<p>In K-C's international operations in Asia, Latin America, the <span class="xn-location">Middle East</span>, Eastern <span class="xn-location">Europe</span> and <span class="xn-location">Africa</span>, personal care sales increased 4 percent. Sales volumes were up 6 percent, spurred by strong growth in <span class="xn-location">China</span> and most of Latin America, while volumes fell significantly in <span class="xn-location">Venezuela</span> in a difficult foreign currency exchange environment. Overall net selling prices decreased 1 percent, as modest declines in several markets were mostly offset by increases in <span class="xn-location">Venezuela</span>. Changes in currency rates reduced sales by 1 percent.</p>
<p/>
<p>Sales of consumer tissue products increased 1.1 percent in the third quarter. Revenue realization strategies led to increased net selling prices of 2 percent and improved product mix of 1 percent, while changes in currency rates reduced sales 2 percent. Sales volumes were even with year-ago levels.</p>
<p/>
<p>In <span class="xn-location">North America</span>, sales of consumer tissue products increased 2 percent compared to the year-ago period. Changes in product mix, including a shift to premium bathroom tissue products, benefited sales by 2 percent, and sales volumes advanced 1 percent. On the other hand, net selling prices were off 1 percent, as increased promotional activity was mostly offset by the benefit from sheet count reductions taken earlier in the year. The increased volumes included 4 percent growth in bathroom tissue, led by improved performance in Cottonelle, and benefits from the Kleenex Hand Towel innovation launched in the first quarter of 2010. Despite improved market shares, Kleenex facial tissue volumes were even with year-ago, reflecting overall category weakness. Paper towel volumes fell at a double-digit rate and continue to be impacted by consumer trade-down.</p>
<p/>
<p>In <span class="xn-location">Europe</span>, consumer tissue sales declined 5 percent compared with the third quarter of 2009, including unfavorable currency effects of 8 percent. Net selling prices improved about 4 percent in response to input cost inflation, while sales volumes and product mix were essentially even with the year-ago period. In K-C's international operations in Asia, Latin America, the <span class="xn-location">Middle East</span>, Eastern <span class="xn-location">Europe</span> and <span class="xn-location">Africa</span>, consumer tissue sales increased 5 percent. Net selling prices increased 6 percent, with improvements in Asia and Latin America, and product mix benefited sales by 1 percent. Sales volumes fell 2 percent due to declines in <span class="xn-location">Venezuela</span>.</p>
<p/>
<p>Sales of K-C Professional (KCP) & other products decreased 3.0 percent compared with the third quarter of 2009. Sales volumes fell 3 percent, reflecting the challenging economic environment, and changes in currency rates reduced sales 2 percent. On the other hand, net selling prices and product mix each increased 1 percent, reflecting the company's continued focus on increasing net realized revenue.</p>
<p/>
<p>In <span class="xn-location">North America</span>, KCP sales decreased 1 percent. Sales volumes were down 3 percent, while net selling prices rose more than 1 percent and currency rates were slightly favorable. Washroom product volumes declined as high unemployment and office vacancy levels continued to impact demand, while high-margin wiper and safety product volumes grew at a solid rate.</p>
<p/>
<p>In <span class="xn-location">Europe</span>, KCP's sales fell 12 percent, including a negative currency effect of 8 percent and a 4 percent decline in sales volumes. In K-C's international operations in Asia, Latin America, the <span class="xn-location">Middle East</span>, Eastern <span class="xn-location">Europe</span> and <span class="xn-location">Africa</span>, KCP's sales increased 6 percent. Net selling prices rose 3 percent and sales volumes advanced 2 percent, with continued gains in Asia. Changes in product mix benefited sales by 1 percent.</p>
<p/>
<p>Sales of health care products increased 4.6 percent in the third quarter. The acquisition of I-Flow Corporation benefited sales by 11 percent, while organic sales volumes declined 4 percent and net selling prices fell 2 percent. The organic volume comparison was adversely affected by approximately 6 points due to increased demand in 2009 for face masks as a result of the H1N1 flu virus. In addition, overall supply volumes in <span class="xn-location">North America</span> this year were impacted by a modest slowdown in market demand. Meanwhile, organic sales volumes for medical devices rose 9 percent globally in the quarter and supply volumes in <span class="xn-location">Europe</span> advanced at a mid-single digit rate.</p>
<pre>
Other third quarter operating results
</pre>
<p>Operating profit was <span class="xn-money">$698 million</span> in the third quarter of 2010, down 20 percent from <span class="xn-money">$871 million</span> in 2009. In addition to the effect of higher net sales, there were a number of other significant factors affecting year-over-year operating profit comparisons. Cost savings in the quarter from the company's FORCE (Focused On Reducing Costs Everywhere) program totaled approximately <span class="xn-money">$95 million</span>. Operating profit comparisons were aided by a <span class="xn-money">$12 million</span> charge for severance and related costs in the year-ago period to streamline the company's organization structure, along with benefits of approximately</p>
<p/>
<p><span class="xn-money">$10 million</span> in the current quarter from the initiative. Pension expense fell by about <span class="xn-money">$20 million</span>, as expected, with a majority of the decrease reflected in cost of sales. Meanwhile, inflation in key cost inputs amounted to about <span class="xn-money">$265 million</span> overall versus 2009, including <span class="xn-money">$170 million</span> in higher fiber costs, <span class="xn-money">$90 million</span> for raw materials other than fiber, primarily polymer resin and other oil-based materials, and <span class="xn-money">$5 million</span> in distribution costs. Lower production volumes as a result of production curtailment to manage inventory levels adversely affected third quarter operating profit comparisons by approximately <span class="xn-money">$20 million</span>. Strategic marketing increased <span class="xn-money">$10 million</span> and research and development spending advanced by a similar amount. General expenses were higher than year-ago levels, driven by the I-Flow acquisition, activity to support growth in K-C International and low overhead spending last year.</p>
<p/>
<p>The company's effective tax rate for the third quarter of 2010 was 30.3 percent. That was in line with the company's full-year guidance for an adjusted rate of 29 to 31 percent, which excludes the effects of the first quarter 2010 charge for the balance sheet remeasurement in <span class="xn-location">Venezuela</span> described below. Last year's third quarter effective tax rate was 29.6 percent.</p>
<p/>
<p>Kimberly-Clark's share of net income of equity companies in the third quarter of 2010 was <span class="xn-money">$40 million</span>, even with year-ago results. Higher earnings at Kimberly-Clark de <span class="xn-location">Mexico</span>, S.A.B. de C.V., spurred by a mid-single digit increase in organic sales, were essentially offset by modestly lower results at other equity affiliates.</p>
<p/>
<p>Net income attributable to noncontrolling interests was <span class="xn-money">$20 million</span> in the third quarter of 2010 compared with <span class="xn-money">$29 million</span> in the prior year. The decrease was primarily due to lower earnings at majority-owned subsidiaries in Asia and the <span class="xn-location">Middle East</span>.</p>
<pre>
Cash flow and balance sheet
</pre>
<p>Cash provided by operations in the third quarter of 2010 totaled <span class="xn-money">$745 million</span> compared to <span class="xn-money">$791 million</span> in the prior year. The decrease was driven by lower cash earnings and a smaller level of improvement in working capital compared to the prior year, mostly offset by lower pension plan contributions. Third quarter contributions to the company's defined benefit pension plans totaled about <span class="xn-money">$2 million</span> in 2010 versus <span class="xn-money">$223 million</span> in 2009.</p>
<p/>
<p>Capital spending for the quarter was <span class="xn-money">$248 million</span> compared with <span class="xn-money">$167 million</span> in 2009. The company now expects that full-year spending will be between <span class="xn-money">$900 million</span> and <span class="xn-money">$1 billion</span>, down slightly from the previous plan for spending at the low end, or potentially slightly below, the target range of <span class="xn-money">$1.0 to $1.1 billion</span>. During the third quarter, the company repurchased approximately 3.1 million shares of its common stock at a cost of <span class="xn-money">$200 million</span>, bringing repurchases for the first nine months of the year to approximately <span class="xn-money">$700 million</span>. Total debt and redeemable securities was <span class="xn-money">$6.5 billion</span> at <span class="xn-chron">September 30, 2010</span>, essentially even with the end of 2009.</p>
<pre>
Year-to-date results
</pre>
<p>For the first nine months of 2010, sales of <span class="xn-money">$14.7 billion</span> increased 3.8 percent, including a favorable currency benefit of 1 percent. Organic sales rose 2 percent, driven by higher net selling prices of 1 percent and increased sales volumes of approximately 1 percent, while the combined impact of the I-Flow Corporation and <span class="xn-location">Jackson</span> Safety acquisitions completed in 2009 added an additional point of sales growth. Year-to-date operating profit of <span class="xn-money">$2,074 million</span> was down 2 percent compared to <span class="xn-money">$2,108 million</span> in 2009. Adjusted operating profit in 2010 of <span class="xn-money">$2,172 million</span> increased 3 percent versus operating profit in the year-ago period. Through nine months, diluted net income per share in 2010 was <span class="xn-money">$3.25</span> and adjusted earnings per share were <span class="xn-money">$3.48</span> compared with diluted net income per share of <span class="xn-money">$3.35</span> in 2009. Adjusted operating profit and adjusted earnings per share in 2010 exclude a one-time charge in the first quarter for the remeasurement of the local currency balance sheet in <span class="xn-location">Venezuela</span> as a result of the adoption of highly inflationary accounting in that country in <span class="xn-chron">January 2010</span>. Additional detail on this item and further information about why the company uses these non-GAAP financial measures are provided later in this news release.</p>
<p/>
<p>Adjusted operating profit comparisons benefited from organic sales growth, FORCE cost savings of <span class="xn-money">$280 million</span>, severance and related costs of <span class="xn-money">$122 million</span> in 2009 to streamline the organization and benefits of <span class="xn-money">$80 million</span> in 2010 from the streamlining initiative. In addition, lower pension expense of <span class="xn-money">$95 million</span> and increased manufacturing volumes as a result of production curtailment in the year-ago period benefited comparisons by approximately <span class="xn-money">$45 million</span>. These positive factors were partially offset by inflation in key cost inputs of about <span class="xn-money">$575 million</span> and increased marketing, research and general expenses, which included higher strategic marketing spending of about <span class="xn-money">$110 million</span> and increases related to the I-Flow acquisition and to support future growth in K-C International.</p>
<pre>
Outlook
</pre>
<p>The company updated several key planning and guidance assumptions for full-year 2010, as follows:</p>
<pre>
-- Net sales increase of approximately 3 percent versus previous guidance
for an increase of 3 to 5 percent.
-- Organic sales are expected to grow 2 percent versus the previous
target range of 2 to 4 percent. Volumes are anticipated to grow 1
percent, and the combination of higher net selling prices and
improved product mix should contribute an additional point of
growth. These estimates take into account results through nine
months, slightly lower estimates for volume growth in North
America
in a difficult economic environment and a modest pick-up in
competitive pricing activity in parts of K-C International.
-- Currency rates are expected to have no overall impact on 2010
sales. This is unchanged from the company's previous guidance.
-- The combined impact of the 2009 acquisitions of I-Flow Corporation
and Jackson Safety should benefit 2010 sales by 1 point. This is
unchanged from the company's prior guidance.
-- Inflation in key cost inputs toward the high end of the company's
previously estimated range of $700 to $800 million. This reflects
estimated average market pricing for benchmark northern softwood pulp
of $950 to $960 per metric ton (previous estimate $930 to $950 per
metric ton) and average oil prices toward the high end of the
company's
prior estimate of $75 to $80 per barrel for the year. While market
pulp costs have fallen some from peak levels in July, the overall
market has been more resilient than the company previously estimated.
-- Adjusted earnings per share in a range of $4.60 to $4.70, up 2 to 4
percent compared to earnings of $4.52 per share in 2009. The
company's
previous guidance in July was that adjusted earnings per share were
more likely to be toward the low end of the target range of $4.80 to
$5.00.
</pre>
<p>Commenting on the outlook, Falk said, "We remain committed to managing those factors we control in the short-term and doing what's right for the long-run health of our business. We will continue to strengthen our brands, pursue our targeted growth initiatives and invest for future growth with higher levels of marketing and innovation spending. We have no plans to cut back on these key investments, and we continue to expect that strategic marketing spending will rise at a faster pace than sales in 2010. At the same time we will continue to leverage our strong financial discipline. We are aggressively reducing costs, with ongoing cost savings expected to easily exceed <span class="xn-money">$300 million</span> this year, and tightly controlling discretionary spending. Moreover, we remain focused on cash generation and allocating it in shareholder-friendly ways, and we now expect to repurchase <span class="xn-money">$800 million</span> worth of KMB stock this year, at the high end of our previous target.</p>
<p/>
<p>"Given our new sales and cost inflation assumptions, we've updated our outlook for 2010 adjusted earnings per share accordingly. While the difficult environment has dampened our earnings growth this year, we are committed to improve performance going forward. We expect earnings per share in the fourth quarter will be similar to, or potentially somewhat higher than, third quarter performance. We anticipate benefits from improved net realized revenue, additional cost savings and somewhat lower pulp costs compared to third quarter levels. At the same time, we are closely monitoring the overall economic environment, particularly market demand in <span class="xn-location">North America</span>. We will continue to successfully execute our strategies to improve shareholder value over time."</p>
<pre>
Non-GAAP financial measures
</pre>
<p>This press release and the accompanying tables include the following financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as nonGAAP financial measures.</p>
<pre>
-- Adjusted earnings and earnings per share
-- Adjusted operating profit
-- Adjusted effective tax rate
</pre>
<p>These non-GAAP financial measures exclude the following item included in the company's earnings, earnings per share, operating profit and effective tax rate for the nine months ended <span class="xn-chron">September 30, 2010</span> calculated in accordance with GAAP:</p>
<pre>
-- Adoption of highly inflationary accounting for our Venezuelan
operations. The company recorded a one-time after tax loss in first
quarter 2010 for the remeasurement of the local currency balance sheet
in Venezuela as a result of the adoption of highly inflationary
accounting in that country effective January 1, 2010. Management does
not consider this loss to be part of our earnings from ongoing
operations for the purposes of evaluating the performance of its
business units and their managers and excludes this loss when making
decisions to allocate resources among its business units.
</pre>
<p>In accordance with the SEC's requirements, reconciliations of the non-GAAP financial measures to the comparable GAAP financial measures are attached.</p>
<p/>
<p>The company provides these non-GAAP financial measures as supplemental information to our GAAP financial measures. Management and the company's Board of Directors use adjusted earnings, adjusted earnings per share and adjusted operating profit to (a) evaluate the company's historical and prospective financial performance and its performance relative to its competitors, (b) allocate resources and (c) measure the operational performance of the company's business units and their managers.</p>
<p/>
<p>Additionally, the Management Development and Compensation Committee of the company's Board of Directors has used the non-GAAP financial measures when setting and assessing achievement of incentive compensation goals. These goals are based, in part, on the company's adjusted earnings per share and improvement in the company's adjusted return on invested capital determined by excluding the charges that are used in calculating these non-GAAP financial measures.</p>
<p/>
<p>In addition, Kimberly-Clark management believes that investors' understanding of the company's performance is enhanced by including these non-GAAP financial measures as a reasonable basis for comparing the company's ongoing results of operations. Many investors are interested in understanding the performance of our businesses by comparing our results from ongoing operations from one period to the next. By providing these non-GAAP financial measures, together with reconciliations, we believe we are enhancing investors' understanding of our businesses and our results of operations. Also, many financial analysts who follow our company focus on and publish both historical results and future projections based on nonGAAP financial measures. We believe that it is in the best interests of our investors for us to provide this information to analysts so that those analysts accurately report the non-GAAP financial information.</p>
<p/>
<p>These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measure. There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. The company compensates for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures. The non-GAAP financial measures should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.</p>
<pre>
Conference call
</pre>
<p>A conference call to discuss this news release and other matters of interest to investors and analysts will be held at <span class="xn-chron">9 a.m. (CDT</span>) today. The conference call will be simultaneously broadcast over the World Wide Web. Stockholders and others are invited to listen to the live broadcast or a playback, which can be accessed by following the instructions set out in the Investors section of the company's Web site (<a href="http://www.kimberly-clark.com">www.kimberly-clark.com</a>).</p>
<pre>
About Kimberly-Clark
</pre>
<p>Kimberly-Clark and its well-known global brands are an indispensable part of life for people in more than 150 countries. Every day, 1.3 billion people - nearly a quarter of the world's population - trust K-C brands and the solutions they provide to enhance their health, hygiene and well-being. With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds No. 1 or No. 2 share positions in more than 80 countries. To keep up with the latest K-C news and to learn more about the company's 138-year history of innovation, visit <a href="http://www.kimberly-clark.com">www.kimberly-clark.com</a>.</p>
<p/>
<p>Copies of Kimberly-Clark's Annual Report to Stockholders and its proxy statements and other SEC filings, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, are made available free of charge on the company's Web site on the same day they are filed with the SEC. To view these filings, visit the Investors section of the company's Web site.</p>
<p/>
<p>Certain matters contained in this news release concerning the business outlook, including anticipated raw material and energy costs, economic conditions, anticipated currency rates and exchange risk, anticipated impact of acquisitions, cost savings, changes in finished product selling prices, cash flow and uses of cash, capital spending, marketing and innovation spending, anticipated benefits related to the organization optimization initiative, anticipated financial and operating results, revenue realization strategies, contingencies and anticipated transactions of the company constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events impacting the company. There can be no assurance that these future events will occur as anticipated or that the company's results will be as estimated. For a description of certain factors that could cause the company's future results to differ materially from those expressed in any such forward-looking statements, see Item 1A of the company's Annual Report on Form 10-K for the year ended <span class="xn-chron">December 31, 2009</span> entitled "Risk Factors."</p>
<pre>
</pre>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
CONSOLIDATED INCOME STATEMENT
PERIODS ENDED SEPTEMBER 30
(Millions of dollars, except per share
amounts)
</pre>
<p> </p>
<pre>
Three Months
Ended
September 30
----------
2010 2009 Change
---- ---- ------
</pre>
<p> </p>
<pre>
Net Sales $4,979 $4,913 + 1.3%
Cost of products sold 3,365 3,186 + 5.6%
----- -----
</pre>
<p> </p>
<pre>
Gross Profit 1,614 1,727 - 6.5%
Marketing, research and
general expenses 909 852 + 6.7%
Other (income) and
expense, net 7 4 +75.0%
--- ---
</pre>
<p> </p>
<pre>
Operating Profit 698 871 - 19.9%
Interest income 5 7 - 28.6%
Interest expense (59) (67) - 11.9%
--- ---
</pre>
<p> </p>
<pre>
Income Before Income
Taxes and Equity
Interests 644 811 - 20.6%
Provision for income -
taxes (195) (240) - 18.8%
---- ----
Income Before Equity
Interests 449 571 - 21.4%
Share of net income of
equity companies 40 40 -
--- ---
</pre>
<p> </p>
<pre>
Net Income 489 611 - 20.0%
Net income attributable
to noncontrolling
interests (20) (29) - 31.0%
--- ---
</pre>
<p> </p>
<pre>
Net Income Attributable
to Kimberly-Clark
Corporation $469 $582 - 19.4%
</pre>
<p> </p>
<p> </p>
<pre>
Per Share Basis -
Diluted Net Income
Attributable to
Kimberly-Clark
Corporation $1.14 $1.40 - 18.6%
</pre>
<p> </p>
<p> </p>
<pre>
Unaudited
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
PERIODS ENDED SEPTEMBER 30
(Millions of dollars)
</pre>
<p> </p>
<pre>
Notes:
1. Organization optimization charges are included in the
Consolidated Income Statement as follows:
</pre>
<p> </p>
<p> </p>
<pre>
Three Months
Ended
September 30
2009
----
Cost of products sold $14
</pre>
<p> </p>
<pre>
Marketing, research and general
expenses (2)
</pre>
<p> </p>
<p>Provision for income taxes (3)</p>
<p> </p>
<p> </p>
<p>Net Charges <span class="xn-money">$9</span></p>
<p> </p>
<p> </p>
<pre>
Unaudited
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
CONSOLIDATED INCOME STATEMENT
PERIODS ENDED SEPTEMBER 30
(Millions of dollars, except per share
amounts)
</pre>
<p> </p>
<pre>
Nine
Months
Ended
September 30
----------
2010 2009 Change
---- ---- ------
</pre>
<p> </p>
<pre>
Net Sales $14,671 $14,133 + 3.8%
Cost of products
sold 9,766 9,379 + 4.1%
----- -----
</pre>
<p> </p>
<pre>
Gross Profit 4,905 4,754 + 3.2%
Marketing, research
and general
expenses 2,719 2,524 + 7.7%
Other (income) and
expense, net 112 122 - 8.2%
--- ---
</pre>
<p> </p>
<pre>
Operating Profit 2,074 2,108 - 1.6%
Interest income 16 21 - 23.8%
Interest expense (180) (211) - 14.7%
---- ----
</pre>
<p> </p>
<pre>
Income Before
Income Taxes and
Equity Interests 1,910 1,918 - 0.4%
Provision for
income taxes (617) (562) + 9.8%
---- ----
Income Before
Equity Interests 1,293 1,356 - 4.6%
Share of net income
of equity
companies 130 116 +12.1%
--- ---
</pre>
<p> </p>
<pre>
Net Income 1,423 1,472 - 3.3%
Net income
attributable to
noncontrolling
interests (72) (80) - 10.0%
--- ---
</pre>
<p> </p>
<pre>
Net Income
Attributable to
Kimberly-Clark
Corporation $1,351 $1,392 - 2.9%
</pre>
<p> </p>
<p> </p>
<pre>
Per Share Basis -
Diluted Net
Income
Attributable to
Kimberly-Clark
Corporation $3.25 $3.35 - 3.0%
</pre>
<p> </p>
<p> </p>
<pre>
Unaudited
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
PERIODS ENDED SEPTEMBER 30
(Millions of dollars, except per share amounts)
Notes:
1. Effective January 1, 2010, the Corporation began accounting for
its Venezuelan subsidiary's operations as highly inflationary and
the subsidiary's functional currency became the U.S. dollar, as
required by U.S. accounting rules. As a result, the Corporation
recorded a one-time after tax charge of $96 million in first
quarter 2010 to remeasure the subsidiary's bolivar-denominated net
monetary asset position into U.S. dollars at a parallel exchange
rate of approximately 6 bolivars per U.S. dollar. This charge was
recorded in the following Consolidated Income Statement line items
for the nine months ended September 30, 2010:
</pre>
<p> </p>
<p> </p>
<p> </p>
<p>Cost of products sold <span class="xn-money">$19</span></p>
<p> </p>
<pre>
Other (income) and
expense, net 79
</pre>
<p> </p>
<pre>
Provision for income
taxes (2)
---
</pre>
<p> </p>
<pre>
Net charge $96
</pre>
<p> </p>
<p> </p>
<pre>
Organization optimization charges are included in the Consolidated
2. Income Statement as follows:
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
Nine Months
Ended
September 30
2009
----
Cost of products sold $41
</pre>
<p> </p>
<p>Marketing, research and general expenses 81</p>
<p> </p>
<pre>
Provision for income taxes (35)
---
</pre>
<p> </p>
<pre>
Net Charges $87
</pre>
<p> </p>
<p> </p>
<pre>
3. Other Information:
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
Nine Months
Ended September
30
----------------
2010 2009
---- ----
Cash Dividends Declared Per Share $1.98 $1.80
</pre>
<p> </p>
<p> </p>
<pre>
September 30
------------
Common Shares (Millions) 2010 2009
------------------------ ---- ----
</pre>
<p> </p>
<p>Outstanding, as of 408.0 414.7</p>
<p> </p>
<pre>
Average Diluted for:
Three Months Ended 412.6 416.8
Nine Months Ended 415.9 416.1
</pre>
<p> </p>
<pre>
Unaudited
</pre>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
PERIODS ENDED SEPTEMBER 30
(Millions of dollars)
</pre>
<p> </p>
<p>Supplemental Financial Information:</p>
<p> </p>
<pre>
Preliminary Balance Sheet Data:
-------------------------------
September December
30 31
2010 2009
---- ----
</pre>
<p> </p>
<p>Cash and cash equivalents <span class="xn-money">$533</span> <span class="xn-money">$798</span></p>
<p> </p>
<p>Accounts receivable, net 2,413 2,566</p>
<p> </p>
<p>Inventories 2,402 2,033</p>
<p> </p>
<p>Total current assets 6,092 5,864</p>
<p> </p>
<p>Total assets 19,486 19,209</p>
<p> </p>
<p>Accounts payable 2,123 1,920</p>
<p> </p>
<p>Debt payable within one year 731 610</p>
<p> </p>
<p>Total current liabilities 5,159 4,923</p>
<p> </p>
<p>Long-term debt 4,710 4,792</p>
<p> </p>
<pre>
Redeemable preferred and common securities of
subsidiaries 1,052 1,052
</pre>
<p> </p>
<pre>
Stockholders' equity 5,934 5,690
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
Three Nine
Months Months
------ ------
Ended Ended
September September
30 30
---------- ----------
Preliminary Cash
Flow Data: 2010 2009 2010 2009
---------------- ---- ---- ---- ----
</pre>
<p> </p>
<pre>
Depreciation and
amortization $205 $196 $607 $563
</pre>
<p> </p>
<pre>
Cash provided by
operations 745 791 1,796 2,480
</pre>
<p> </p>
<p>Capital spending 248 167 611 563</p>
<p> </p>
<pre>
Cash used for
investing 223 152 512 748
</pre>
<p> </p>
<p>Cash dividends paid 271 249 796 737</p>
<p> </p>
<pre>
Cash used for
financing 594 480 1,506 1,369
</pre>
<p> </p>
<pre>
Unaudited
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
PERIODS ENDED SEPTEMBER 30
</pre>
<p> </p>
<p> </p>
<p>Description of Business Segments</p>
<p> </p>
<pre>
The Corporation is organized into operating segments based on product
groupings. These operating segments have been aggregated into four
reportable global business segments: Personal Care; Consumer
Tissue; K-C Professional & Other; and Health Care. The reportable
segments were determined in accordance with how the Corporation's
executive managers develop and execute the Corporation's global
strategies to drive growth and profitability of the Corporation's
worldwide Personal Care, Consumer Tissue, K-C Professional & Other,
and Health Care operations. These strategies include global plans
for branding and product positioning, technology, research and
development programs, cost reductions including supply chain
management, and capacity and capital investments for each of these
businesses. Segment management is evaluated on several factors,
including operating profit. Segment operating profit excludes other
income and (expense), net and income and expense not associated with
the business segments.
</pre>
<p> </p>
<pre>
The principal sources of revenue in each of our global business
segments are described below.
</pre>
<p> </p>
<pre>
The Personal Care segment manufactures and markets disposable
diapers, training and youth pants and swimpants; baby wipes;
feminine and incontinence care products; and related products.
Products in this segment are primarily for household use and are
sold under a variety of brand names, including Huggies, Pull-Ups,
Little Swimmers, GoodNites, Kotex, Lightdays, Depend, Poise and
other brand names.
</pre>
<p> </p>
<pre>
The Consumer Tissue segment manufactures and markets facial and
bathroom tissue, paper towels, napkins and related products for
household use. Products in this segment are sold under the Kleenex,
Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, Page and other
brand names.
</pre>
<p> </p>
<pre>
The K-C Professional & Other segment manufactures and markets facial
and bathroom tissue, paper towels, napkins, wipers and a range of
safety products for the away-from-home marketplace. Products in
this segment are sold under the Kimberly-Clark, Kleenex, Scott,
WypAll, Kimtech, KleenGuard, Kimcare and Jackson brand names.
</pre>
<p> </p>
<pre>
The Health Care segment manufactures and markets disposable health
care products such as surgical drapes and gowns, infection control
products, face masks, exam gloves, respiratory products, pain
management products and other disposable medical products. Products
in this segment are sold under the Kimberly-Clark, Ballard, ON-Q
and other brand names.
</pre>
<p> </p>
<pre>
Unaudited
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
SELECTED BUSINESS SEGMENT DATA
PERIODS ENDED SEPTEMBER 30
(Millions of dollars)
</pre>
<p> </p>
<pre>
Three Months Nine Months
Ended September 30 Ended September 30
------------------ ------------------
2010 2009 Change 2010 2009 Change
---- ---- ------ ---- ---- ------
</pre>
<p> </p>
<p> </p>
<p>NET SALES:</p>
<p> </p>
<pre>
Personal Care $2,183 $2,132 + 2.4% $6,501 $6,231 + 4.3%
Consumer
Tissue 1,643 1,625 + 1.1% 4,778 4,754 + 0.5%
K-C
Professional 3.0%
& Other 781 805 - 2,312 2,192 + 5.5%
Health Care 367 351 + 4.6% 1,078 984 + 9.6%
</pre>
<p> </p>
<pre>
Corporate &
Other 11 11 N.M. 36 38 N.M.
</pre>
<p> </p>
<pre>
Intersegment
Sales (6) (11) N.M. (34) (66) N.M.
--- --- --- ---
</pre>
<p> </p>
<pre>
Consolidated $4,979 $4,913 + 1.3% $14,671 $14,133 + 3.8%
====== ====== ======= =======
</pre>
<p> </p>
<pre>
OPERATING
PROFIT(a):
</pre>
<p> </p>
<pre>
-
Personal Care $428 $467 8.4% $1,343 $1,303 + 3.1%
Consumer
Tissue 156 232 - 32.8% 488 587 - 16.9%
K-C
Professional
& Other 116 163 - 28.8% 356 345 + 3.2%
Health Care 49 78 - 37.2% 148 188 - 21.3%
</pre>
<p> </p>
<pre>
Corporate &
Other(b) (44) (65) - 32.3% (149) (193) - 22.8%
</pre>
<p> </p>
<pre>
Other income
and
(expense),
net(b)(c) (7) (4) + 75.0% (112) (122) - 8.2%
--- --- ---- ----
</pre>
<p> </p>
<pre>
Consolidated $698 $871 - 19.9% $2,074 $2,108 - 1.6%
==== ==== ====== ======
</pre>
<p> </p>
<p> </p>
<pre>
(a) Organization optimization charges in 2009 are included by business
segment as follows:
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
Three Months Nine Months
Ended September Ended September
30 30
2009 2009
---- ----
</pre>
<p> </p>
<pre>
Personal Care $3 $44
Consumer Tissue 5 47
K-C Professional & Other 2 16
Health Care 6
Corporate & Other 2 9
</pre>
<p> </p>
<pre>
Total $12 $122
====
</pre>
<p> </p>
<pre>
N.M. - Not meaningful
Unaudited
</pre>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
SELECTED BUSINESS SEGMENT DATA
PERIODS ENDED SEPTEMBER 30
</pre>
<p> </p>
<pre>
(b) For the nine months ended September 30, 2010, Corporate & Other
includes a one-time $19 million charge and Other income and
(expense), net includes a one-time $79 million charge related to
the adoption of highly inflationary accounting in Venezuela.
(c) Other income and (expense), net, includes the following amounts
of currency transaction losses.
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
Three Months Nine Months
Ended September 30 Ended September 30
------------------ ------------------
2010 2009 2010 2009
---- ---- ---- ----
</pre>
<p> </p>
<pre>
Other income and
(expense), net $ - $(13) $(26) $(109)
</pre>
<p> </p>
<p> </p>
<pre>
PERCENTAGE CHANGE IN NET SALES VERSUS PRIOR YEAR
</pre>
<p> </p>
<p> </p>
<pre>
Three Months Ended September 30, 2010
-------------------------------------
Organic Acquisition Total Net Mix/
Total Volume Volume(1) Volume Price Other(2) Currency
----- ------ -------- ------ ----- ------- --------
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
Consolidated 1.3 1 1 2 - - (1)
Personal
Care 2.4 5 - 5 (1) (1) (1)
Consumer
Tissue 1.1 - - - 2 1 (2)
K-C
Professional &
Other (3.0) (3) - (3) 1 1 (2)
Health Care 4.6 (4) 11 7 (2) - -
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
Nine Months Ended September 30, 2010
------------------------------------
Organic Acquisition Total Net Mix/
Total Volume Volume(3) Volume Price Other(2)
Currency
----- ------ -------- ------ ----- -------
--------
</pre>
<p> </p>
<p> </p>
<p> </p>
<pre>
Consolidated 3.8 1 1 2 1 -
1
Personal Care 4.3 3 - 3 - -
1
Consumer Tissue 0.5 (3) - (3) 2 1
1
K-C Professional
& Other 5.5 (1) 2 1 3 -
1
Health Care 9.6 (1) 11 10 (2) 1
1
</pre>
<p> </p>
<p> </p>
<pre>
(1) Volume related to the acquisition of I-Flow Corporation.
(2) Mix/Other includes rounding.
(3) Volume related to the acquisition of Jackson Safety and I-Flow
Corporation.
</pre>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
PERIODS ENDED SEPTEMBER 30
(Millions of dollars, except per share amounts)
</pre>
<p> </p>
<p>NON-GAAP RECONCILIATION SCHEDULES</p>
<p> </p>
<pre>
The tables on the following pages present the reconciliation of non-
GAAP financial measures to GAAP financial measures.
</pre>
<p> </p>
<p>EARNINGS SUMMARY:</p>
<p> </p>
<pre>
Nine Months
Ended
September
30, 2010
---------
Diluted
Income Earnings
Per
(Expense) Share
--------- ------
</pre>
<p> </p>
<p>Adjusted Earnings <span class="xn-money">$1,447</span> <span class="xn-money">$3.48</span></p>
<p> </p>
<pre>
Adjustments for the one-
time charge related to
adoption of highly
inflationary accounting in
Venezuela (96) (0.23)
--- -----
</pre>
<p> </p>
<pre>
Net Income Attributable to
Kimberly-Clark
Corporation $1,351 $3.25
====== =====
</pre>
<p> </p>
<p> </p>
<pre>
OPERATING PROFIT SUMMARY:
Nine
Months
Ended
September
30
2010
----
Adjusted Operating Profit $2,172
</pre>
<p> </p>
<pre>
Adjustments for the one-time
charge related to adoption of
highly inflationary accounting
in Venezuela (98)
---
</pre>
<p> </p>
<pre>
Operating Profit $2,074
======
</pre>
<p> </p>
<p> </p>
<pre>
KIMBERLY-CLARK CORPORATION
PERIODS ENDED SEPTEMBER 30
</pre>
<p> </p>
<p> </p>
<p>OUTLOOK FOR 2010</p>
<p> </p>
<pre>
Estimated Full-Year 2010 Diluted
Earnings Per Share:
Adjusted Earnings Per Share $4.60 - $4.70
</pre>
<p> </p>
<pre>
Adjustments for the one-time
charge related to adoption of
highly inflationary accounting
in Venezuela (.23) (.23)
---- ----
</pre>
<p> </p>
<pre>
Earnings Per Share - Diluted $4.37 - $4.47
</pre>
<p> </p>
<p> </p>
<p>Estimated Full-Year Effective Tax Rate:</p>
<p> </p>
<p>Adjusted Effective Tax Rate 29% - 31%</p>
<p> </p>
<pre>
Adjustments for the one-time
charge related to adoption of
highly inflationary accounting
in Venezuela 1% 1%
--- ---
</pre>
<p> </p>
<pre>
Effective Tax Rate 30% - 32%
=== ===
For further information: Investor Relations, Paul Alexander, +1-972-281-1440, [email protected], or Media Relations, Kay Jackson, +1-972-281-1486, [email protected], both of Kimberly-Clark Corporation Web Site: http://www.kimberly-clark.com
Share this article